Click here to download the e-book!
Small molecules may be over a century old, but they’re far from old-fashioned. Our new ebook, Small Molecules, Global Challenges, brings together perspectives from across industry and academia to explore how innovation and crazy chemistry is reshaping the space.
Experts explore AI’s role in tackling long-standing formulation challenges, including how machine learning tools are being used to predict solubility and optimize co-crystals, potentially shortening timelines and opening access to new chemical space.
Environmental responsibility also features prominently. Contributors argue that early attention to green chemistry in API development can yield scalable, sustainable processes without slowing timelines or sacrificing yield. For example, process intensification, solvent recovery, and continuous flow can cut costs while reducing environmental impact.
Also covered in the eBook, we interview Ali Tavassoli from Curve Therapeutics. His work on protein-protein interactions can potentially address one of the most challenging areas in drug discovery: targeting the complex surfaces where proteins bind to each other to regulate vital biological functions.
We also speak with Colorcon CEO Simon Tasker. He joined the company as a bench chemist and never left. Talk about an incredible career progression! He says, “When I was interviewed for the CEO position at Colorcon, I was asked: 'Why do you think you’re well suited to do this job?' My reply was simply, 'Because I know how these products smell and taste. I’ve held so many roles within this organization that it’s in my DNA at this point.'”
Download the eBook for free. And if you have expertise and thought leadership you’d like to share in the traditional small molecule drug development space then get in touch at stephanie.vine@conexiant.com.